• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infez Med . Can a quantitative assessment of SARS-CoV-2 PCR predict degree of severity and outcomes in critical care patients with COVID-19?

tetano

Editor, Senior Moderator
Infez Med


. 2021 Sep 10;29(3):386-392.
doi: 10.53854/liim-2903-9. eCollection 2021.
Can a quantitative assessment of SARS-CoV-2 PCR predict degree of severity and outcomes in critical care patients with COVID-19?


Rosalind Stonham[SUP] 1 [/SUP], Chantelle Monck[SUP] 2 [/SUP], Laurence Orchard[SUP] 1 [/SUP], Laurence Baker[SUP] 1 [/SUP], Nusreen Ahmad-Saeed[SUP] 2 [/SUP], Simon Friar[SUP] 2 [/SUP], Buddhini Samaraweera[SUP] 2 3 [/SUP], Adhyana Mahanama[SUP] 2 3 [/SUP], Emanuela Pelosi[SUP] 2 4 [/SUP], Eleri Wilson-Davies[SUP] 2 [/SUP], Ahilanandan Dushianthan[SUP] 1 4 5 [/SUP], Kordo Saeed[SUP] 4 6 [/SUP]



Affiliations

Abstract

Real-Time polymerase chain reaction (qPCR) is the gold standard diagnostic method for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Cycle threshold (Ct) is defined as the number of heating and cooling cycles required during the PCR process. Ct-values are inversely proportional to the amount of target nucleic acid in a sample. Our aim, in this retrospective study, was to determine the impact of serial SARS-CoV-2 qPCR Ct-values on: mortality, need for mechanical ventilation (MV) and development of acute kidney injury (AKI) in patients admitted to the intensive care unit (ICU) with COVID-19. Ct values were evaluated during the time points from pre-ICU admission to week 1, week 2 and week 3 during ICU stay; impact on mortality, need for MV and AKI was determined. There was a continuous increment in Ct-values over the ICU stay from 1[SUP]st[/SUP] week through to 3[SUP]rd[/SUP] week. Although not significant, lower ICU 1[SUP]st[/SUP] week Ct-values were associated with Black ethnicity, increased need for MV and mortality. However, patients who had developed AKI at any stage of their illness had significantly lower Ct-values compared to those with normal renal function. When ICU 1[SUP]st[/SUP]-week Ct-values are subcategorised as <20, 20-30 and >30 the 28-day survival probability was less for patients with Ct-values of <20. This report shows that the impact of Ct-values and outcomes, especially AKI, among patients at different time points prior to and during ICU stay, larger studies are required to confirm out findings.

Keywords: COVID-19; Ct values PCR; SARS-CoV-2; intensive care; qPCR.
 
Back
Top Bottom